Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2014

[GlobeNewswire] – PHILADELPHIA — Hemispherx Biopharma (NYSE MKT:HEB) announced its financial results for the three months ended March 31, 2014. The net loss (including non-cash effects) was approximately $3,836,000 or … more

View todays social media effects on HEB

View the latest stocks trending across Twitter. Click to view dashboard

See who Hemispherx is hiring next, click here to view